一个交叉连接的聚乙醇核心外微针贴片,用于完全和可控的胰岛素输送和持续的低血糖治疗
Ye He1, Yuxuan Zhang2, Kaiyue An2
1Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Colloids and surfaces. B, Biointerfaces
|August 19, 2025
概括
这项研究引入了一种新的微针贴片,用于完全输送胰岛素,在糖尿病小鼠中持续控制血糖. 创新的设计增强了药物负载和生物可用性,以改善低血糖治疗.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 纳米技术纳米技术
背景情况:
- 微针技术旨在实现完整和可控的药物输送.
- 现有的微针在制造和药物装载能力方面存在局限性,特别是对于高剂量和难溶性药物.
研究的目的:
- 设计和评估一种新型的粉末装载交联聚乙烯醇微针贴片,用于完全和可控的高剂量胰岛素输送.
- 在糖尿病模型中实现持续的低血糖治疗.
主要方法:
- 一个核心外微针结构的制造,其中有一个药物推进核心和受控释放外.
- 在微针贴片内直接封装固体胰岛素.
- 在体外释放研究以评估胰岛素释放动力学.
- 在糖尿病小鼠体内对含胰岛素的微针贴片进行体内评估,以评估疗效和生物可用性.
主要成果:
- 这种新型的微针贴片通过协同的核心-外相互作用证明了完全和定制的胰岛素释放.
- 直接胰岛素封装显著提高了药物负载能力,并最大限度地降低了降解.
- 含胰岛素的微针贴片在糖尿病小鼠中维持了高达12小时的血糖正常.
- 达到了高达80.2%的高生物利用率,超过了传统的聚合物微针.
结论:
- 开发的核心外微针贴片为完全和可控的高剂量药物输送提供了一个有前途的解决方案,特别是对于胰岛素.
- 这项技术解决了微针制造和药物加载当前的局限性,显示了在糖尿病管理中临床应用的潜力.
相关概念视频
01:27Insulin Formulations: Types and Delivery
270
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
270
01:25Insulin: Biosynthesis, Chemistry, and Preparation
523
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
523
01:05Insulin Secretory Vesicles
5.4K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.4K
01:16Insulin: Dosing Regimen and Adverse Effects
257
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
257
01:22Drug Delivery: Miscellaneous Routes
468
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
468
01:28Insulin: The Receptor and Signaling Pathways
1.5K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.5K